Related Experiment Videos
Bioadhesion: new possibilities for drug administration?
1Laboratoire Cinétique des Xénobiotiques, Faculty of Pharmacy, Toulouse, France. woodley@cict.fr
Clinical Pharmacokinetics
|April 5, 2001
Summary
Bioadhesion, the sticking of materials to mucosal surfaces, enhances drug delivery. Novel bioadhesive micro- and nanoparticles show promise for targeted drug absorption and extended release.
Area of Science:
- Pharmaceutical Sciences
- Biomaterials Science
- Drug Delivery Systems
Background:
- Bioadhesion involves macromolecules adhering to mucosal surfaces, enhancing drug absorption or enabling sustained release.
- Synthetic polymers (chitosans, carbopols) and biological agents (plant lectins) mediate bioadhesion through physicochemical and specific interactions.
- Advancements in bioadhesive formulations are being made for various administration routes.
Purpose of the Study:
- To review the mechanisms and applications of bioadhesion in pharmaceutical formulations.
- To explore the development of bioadhesive systems for enhanced drug delivery.
- To identify challenges and future directions in bioadhesive drug administration.
Main Methods:
- Review of physicochemical interactions of synthetic polymers (chitosans, carbopols) for bioadhesion.
- Analysis of specific interactions of biological bioadhesives (plant lectins) with mucosal surfaces.
- Examination of current and developing bioadhesive formulations for buccal, nasal, vaginal, and gastrointestinal drug delivery.
Main Results:
- Bioadhesive systems for buccal and nasal drug delivery are nearing market availability, utilizing microparticles for nasal applications.
- A bioadhesive vaginal drug delivery formulation is currently in use.
- Micro- and nanoparticles coated with bioadhesive polymers show potential for gastrointestinal drug delivery, despite challenges.
Conclusions:
- Bioadhesion offers significant potential for improving drug absorption and extending drug release at mucosal sites.
- While buccal, nasal, and vaginal applications are advancing, gastrointestinal drug delivery faces challenges due to mucus turnover and transit times.
- Further research and development are crucial for realizing the full potential of advanced bioadhesive micro- and nanoparticles, especially for challenging routes like the GI tract.